Gain Therapeutics, Inc. (GANX)

Gain Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	11.79	7.31	36.88	7.5	0.3
Short-Term Investments	5	12.83	0	0	0
Cash & Cash Equivalents	16.79	20.14	36.88	7.5	0.3
Cash Growth	-16.60%	-45.40%	391.46%	2374.05%	-
Receivables	0	0	0	0.01	0.01
Other Current Assets	0.98	0.95	0.84	1.47	0.12
Total Current Assets	17.78	21.09	37.72	8.99	0.43
Property, Plant & Equipment	0.59	0.8	1.01	0.55	0.22
Long-Term Investments	0.03	1.97	0.03	0	0.01
Goodwill and Intangibles	0.19	0.21	0.2	0	0
Other Long-Term Assets	0.02	0.02	0.02	0.06	0
Total Long-Term Assets	0.83	3.01	1.26	0.62	0.23
Total Assets	18.61	24.1	38.99	9.6	0.66
Accounts Payable	1.32	1.63	0.56	0.96	0.15
Deferred Revenue	1.22	0.06	0.27	0.24	0.37
Current Debt	0.35	0.34	0.32	0.15	0.1
Other Current Liabilities	2.07	2.11	1.4	0.77	0.25
Total Current Liabilities	4.95	4.13	2.55	2.11	0.88
Long-Term Debt	0.68	0.94	1.29	1.12	0.1
Other Long-Term Liabilities	0.4	0.16	0.33	0.17	0.13
Total Long-Term Liabilities	1.08	1.09	1.61	1.29	0.23
Total Liabilities	6.03	5.22	4.17	3.4	1.11
Total Debt	1.03	1.27	1.61	1.26	0.21
Debt Growth	-19.37%	-20.78%	27.52%	510.63%	-
Retained Earnings	-60.78	-38.52	-20.93	-7.03	-3.46
Comprehensive Income	0.25	0.04	-0.09	-0.15	-0.08
Shareholders' Equity	12.58	18.88	34.82	6.2	-0.45
Net Cash / Debt	15.77	18.86	35.27	6.24	0.1
Net Cash / Debt Growth	-16.42%	-46.52%	465.00%	6352.50%	-
Net Cash Per Share	1.21	1.59	3.47	2.33	0.04
Working Capital	12.83	16.97	35.17	6.87	-0.45
Book Value Per Share	0.97	1.59	3.42	2.31	-0.20

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).